Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort

• Published in: BioMed research international Vol. 2018; no. 2018; pp. 1 - 9
• Main Authors: Griger, Zoltán, Szodoray, Peter, Zilahi, Erika, Vincze, Anett, Nagy-Vincze, Melinda, Bodoki, Levente, Szabó, Katalin, Dankó, Katalin
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2018; Hindawi; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Adult; Antibodies; Antibodies, Antinuclear - blood; Antigens; Arthritis; Autoantibodies; B cells; C-Reactive Protein - metabolism; Cohort Studies; Collaboration; Creatine Kinase - blood; Dendritic cells; Deoxyribonucleic acid; Development and progression; Diagnosis; Disease Progression; DNA; Dose-Response Relationship, Drug; DQA1 protein; Drb1 protein; Dysphagia; Ethylenediaminetetraacetic acid; Female; Fever; Histocompatibility antigen HLA; Histocompatibility antigens; HLA histocompatibility antigens; Humans; Hungary; Immunoglobulins; Immunology; Immunosuppressive agents; Inflammatory diseases; Laboratories; Lesions; Lung diseases; Male; Markers; Medical research; Medicine, Experimental; Methylprednisolone - therapeutic use; Musculoskeletal diseases; Myositis; Myositis - blood; Myositis - drug therapy; Myositis - genetics; Myositis - pathology; Patients; Phenotypes; Prognosis; Respiratory tract diseases; Rheumatic diseases; Rheumatology; Ribonucleoproteins - blood; Skin; Skin diseases; Viral antibodies; Hungary; Germany
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2018/6416378

The aim of this study was to determine the clinical, serological, and genetic features of anti-Jo-1 positive antisynthetase patients followed by a Hungarian single centre to identify prognostic markers, which can predict disease phenotypes and disease progression. It was a retrospective study using clinical database of 49 anti-Jo-1 positive patients. 100% of patients exhibited myositis, 73% interstitial lung disease, 88% arthritis, 65% Raynaud’s phenomenon, 43% fever, 33% mechanic’s hand, and 12% dysphagia. We could detect significant correlation between anti-Jo-1 titer and the CK and CRP levels at disease onset and during disease course. HLA DRB1⁎03 positivity was present in 68.96% of patients, where the CK level at diagnosis was significantly lower compared to the HLA DRB1⁎03 negative patients. HLA DQA1⁎0501-DQB1⁎0201 haplotype was found in 58.62% of patients, but no significant correlation was found regarding any clinical or laboratory features. Higher CRP, ESR level, RF positivity, and the presence of fever or vasculitic skin lesions at the time of diagnosis indicated a higher steroid demand and the administration of higher number of immunosuppressants during the follow-up within anti-Jo-1 positive patients. The organ involvement of the disease was not different in HLA-DRB1⁎0301 positive or negative patients who were positive to the anti-Jo-1 antibody; however, initial CK level was lower in HLA-DRB1⁎0301 positive patients. Distinct laboratory and clinical parameters at diagnosis could be considered as prognostic markers.